Company registration number 07698454 (England and Wales)
PROTEC HEALTHCARE PRODUCTS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
PROTEC HEALTHCARE PRODUCTS LIMITED
COMPANY INFORMATION
Directors
Mr B L Furse
Mrs K S Furse
Company number
07698454
PROTEC HEALTHCARE PRODUCTS LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
PROTEC HEALTHCARE PRODUCTS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
22,459
-
0
Tangible assets
4
106,642
142,581
129,101
142,581
Current assets
Stocks
114,293
148,975
Debtors
5
376,940
470,466
Cash at bank and in hand
371,778
488,115
863,011
1,107,556
Creditors: amounts falling due within one year
6
(509,322)
(518,937)
Net current assets
353,689
588,619
Total assets less current liabilities
482,790
731,200
Creditors: amounts falling due after more than one year
7
-
0
(69,194)
Provisions for liabilities
3,540
(18,723)
Net assets
486,330
643,283
Capital and reserves
Called up share capital
10,001
10,001
Profit and loss reserves
476,329
633,282
Total equity
486,330
643,283

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

PROTEC HEALTHCARE PRODUCTS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2025
31 December 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 3 June 2026 and are signed on its behalf by:
Mr B L Furse
Director
Company Registration No. 07698454
PROTEC HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Protec Healthcare Products Limited is a private company limited by shares incorporated in England and Wales. The registered office is 9 Tregarne Terrace, St Austell, Cornwall, PL25 4DD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.4
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of the business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

1.5
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Website
33% per annum on the straight line method
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

PROTEC HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% per annum on the reducing balance method
Fixtures and fittings
25% per annum on the reducing balance method
Motor vehicles
33% per annum on the reducing balance method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell after making due allowance for obsolete and slow moving stock.

1.9
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10
Debtors and creditors receivable/payable within one year

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

PROTEC HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -
1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
9
9
PROTEC HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
3
Intangible fixed assets
Goodwill
Website
Total
£
£
£
Cost
At 1 January 2025
437,000
-
0
437,000
Additions
-
0
24,500
24,500
At 31 December 2025
437,000
24,500
461,500
Amortisation and impairment
At 1 January 2025
437,000
-
0
437,000
Amortisation charged for the year
-
0
2,041
2,041
At 31 December 2025
437,000
2,041
439,041
Carrying amount
At 31 December 2025
-
0
22,459
22,459
At 31 December 2024
-
0
-
0
-
0
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2025
73,148
13,349
178,721
265,218
Additions
11,009
5,956
151,032
167,997
Disposals
(22,145)
(5,210)
(196,026)
(223,381)
At 31 December 2025
62,012
14,095
133,727
209,834
Depreciation and impairment
At 1 January 2025
50,256
5,570
66,811
122,637
Depreciation charged in the year
6,699
2,461
47,465
56,625
Eliminated in respect of disposals
(12,652)
(2,019)
(61,399)
(76,070)
At 31 December 2025
44,303
6,012
52,877
103,192
Carrying amount
At 31 December 2025
17,709
8,083
80,850
106,642
At 31 December 2024
22,892
7,779
111,910
142,581

Motor vehicles with a carrying value of £67,415 (20 24: £109,466) are held under hire purchase contracts.

PROTEC HEALTHCARE PRODUCTS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
5
Debtors: amounts falling due within one year
2025
2024
£
£
Trade debtors
175,617
203,906
Other debtors
201,323
266,560
376,940
470,466
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
190,772
198,523
Corporation tax
108,364
86,985
Other taxation and social security
32,835
20,805
Other creditors
177,351
212,624
509,322
518,937
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
-
0
69,194

Hire purchase agreements are secured against the assets to which they relate. The outstanding amount at 31 December 20 25 was £75,599 (20 24: £109,056). See note 5.

8
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
15,759
27,314
9
Parent company

The parent company of Protec Healthcare Products Limited is Protec Global Holdings Limited and its registered office is 68 Victoria Road, Mount Charles, St Austell, Cornwall, PL25 4QD.

2025-12-31 2025-01-01 false false false 03 June 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr B L Furse Mrs K S Furse 07698454 2025-01-01 2025-12-31 07698454 bus:Director1 2025-01-01 2025-12-31 07698454 bus:Director2 2025-01-01 2025-12-31 07698454 2025-12-31 07698454 2024-12-31 07698454 core:Goodwill 2025-12-31 07698454 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-12-31 07698454 core:Goodwill 2024-12-31 07698454 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 07698454 core:PlantMachinery 2025-12-31 07698454 core:FurnitureFittings 2025-12-31 07698454 core:MotorVehicles 2025-12-31 07698454 core:PlantMachinery 2024-12-31 07698454 core:FurnitureFittings 2024-12-31 07698454 core:MotorVehicles 2024-12-31 07698454 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 07698454 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07698454 core:CurrentFinancialInstruments 2025-12-31 07698454 core:CurrentFinancialInstruments 2024-12-31 07698454 core:Non-currentFinancialInstruments 2025-12-31 07698454 core:Non-currentFinancialInstruments 2024-12-31 07698454 core:ShareCapital 2025-12-31 07698454 core:ShareCapital 2024-12-31 07698454 core:RetainedEarningsAccumulatedLosses 2025-12-31 07698454 core:RetainedEarningsAccumulatedLosses 2024-12-31 07698454 core:Goodwill 2025-01-01 2025-12-31 07698454 core:IntangibleAssetsOtherThanGoodwill 2025-01-01 2025-12-31 07698454 core:PlantMachinery 2025-01-01 2025-12-31 07698454 core:FurnitureFittings 2025-01-01 2025-12-31 07698454 core:MotorVehicles 2025-01-01 2025-12-31 07698454 2024-01-01 2024-12-31 07698454 core:Goodwill 2024-12-31 07698454 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 07698454 2024-12-31 07698454 core:Goodwill core:InternallyGeneratedIntangibleAssets 2025-01-01 2025-12-31 07698454 core:DevelopmentCostsCapitalisedDevelopmentExpenditure core:InternallyGeneratedIntangibleAssets 2025-01-01 2025-12-31 07698454 core:InternallyGeneratedIntangibleAssets 2025-01-01 2025-12-31 07698454 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-01-01 2025-12-31 07698454 core:PlantMachinery 2024-12-31 07698454 core:FurnitureFittings 2024-12-31 07698454 core:MotorVehicles 2024-12-31 07698454 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07698454 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07698454 bus:FRS102 2025-01-01 2025-12-31 07698454 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 07698454 bus:FullAccounts 2025-01-01 2025-12-31 xbrli:pure xbrli:shares iso4217:GBP